Institutional Ownership
Inhibikase Therapeutics Inc
CUSIP 45719W205COM NEWIKTQ1 2026
Institutional Holders
100
13F filers
Shares Held
109.47M
Aggregate institutional
Institutional Value
$183.50M
Q1 2026
Net New Holders
+28
36 new · 8 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions36
Increased38
Decreased14
Sold out8
Institutional Holders
100 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | 13.02M | $21.87M | 0 | Held |
| 2 | Soleus Capital Management, L.P. | 10.88M | $18.27M | 0 | Held |
| 3 | Fairmount Funds Management LLC | 8.63M | $14.49M | 0 | Held |
| 4 | Trails Edge Capital Partners, LP | 8.06M | $13.54M | +1.88M | Added |
| 5 | Adar1 Capital Management, LLC | 6.61M | $11.10M | −1.46M | Reduced |
| 6 | Blackrock, Inc. | 6.30M | $10.59M | +3.00M | Added |
| 7 | Blackstone Inc. | 5.94M | $9.98M | +5.94M | New |
| 8 | Siren, L.L.C. | 5.85M | $9.83M | 0 | Held |
| 9 | Commodore Capital LP | 5.40M | $9.07M | 0 | Held |
| 10 | Saturn V Capital Management LP | 3.86M | $6.49M | +6.6K | Added |
90 more institutional holders on Premium
See every fund holding Inhibikase Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders